The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Institutional treatment volume and outcomes in salivary gland cancer.
 
Conor Ernst Steuer
Consulting or Advisory Role - Boehringer Ingelheim; EMD Serono
 
Jeffrey M. Switchenko
No Relationships to Disclose
 
Christopher C Griffith
No Relationships to Disclose
 
Mihir Patel
No Relationships to Disclose
 
Richard John Cassidy
No Relationships to Disclose
 
Theresa Wicklin Gillespie
No Relationships to Disclose
 
Mark William McDonald
No Relationships to Disclose
 
Kristin Ann Higgins
No Relationships to Disclose
 
Jonathan Jay Beitler
Stock and Other Ownership Interests - GE Healthcare
 
Taofeek Kunle Owonikoko
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Eisai; G1 Therapeutics; Genentech/Roche; Lilly; Novartis; Sandoz; Takeda
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); G1 Therapeutics (Inst); Novartis (Inst); Regeneron (Inst); Stem CentRx (Inst)
Patents, Royalties, Other Intellectual Property - OVERCOMING ACQUIRED RESISTANCE TO CHEMOTHERAPY TREATMENTS THROUGH SUPPRESSION OF STAT3 (Inst); SELECTIVE CHEMOTHERAPY TREATMENTS AND DIAGNOSTIC METHODS RELATED THERETO (Inst)
 
Zhuo Georgia Chen
No Relationships to Disclose
 
Dong Moon Shin
No Relationships to Disclose
 
Nabil F. Saba
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck; Pfizer